Natco’s settlement of patent case with Gilead covering 30 mg, 45 mg and 75 mg versions of Tamiflu - Prometheus IP

December 21, 2015by prometheusip0

Natco Pharma Ltd and its partner Alvogen Inc. have settled a patent infringement case with US drug maker Gilead Sciences Inc., and Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd and Genentech Inc., thus clearing the way into the world’s largest pharmaceutical market for the Indian drug maker in terms of launching generic versions of anti-influenza drug, Tamiflu [more].

prometheusip

Prometheus IP is a leading intellectual property service enterprise offering competent and economic Intellectual Property Rights (IPR) solutions which include Patents, Designs, Copyrights and Trademarks.

Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.